The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
This research study is designed to develop and test a new supportive care program to help individuals with lung cancer improve their quality of life after cancer treatment is over.
Checked against the public recordLast updated Mar 27, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Massachusetts General Hospital
- Interventions being studied
- Behavioral: Run-In Sessions 1-5; Behavioral: RCT Transitions Program Sessions 1-5; Behavioral: RCT Control Session
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age 21 or older * Diagnosis of non-small cell (NSCLC) or small cell (SCLC) lung cancer or mesothelioma * Documented treatment plan with curative intent * Ability to read and respond in English * Treatment completion eligibility: Run-in: Has completed treatment including systemic treatments and radiation as determined within the past three weeks by the cancer care team at Massachusetts General Hospital. RCT: Has completed treatment including systemic treatments +/- radiation and +/- surgery. 1. If final treatment is systemic therapy +/- radiation: within three weeks after cancer care team determination that treatment is complete. 2. If final treatment is surgery: within three weeks after hospital discharge following surgery. Exclusion Criteria: * Comorbid health condition that would interfere with study participation * Current participation in cognitive behavioral therapy treatment
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Massachusetts General HospitalBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 27, 2026. Always confirm current availability with the study team.